A detailed history of Point72 Europe (London) LLP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 11,100 shares of MEDP stock, worth $4.47 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
11,100
Previous 65 16976.92%
Holding current value
$4.47 Million
Previous $19,000 23510.53%
% of portfolio
0.42%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $3.14 Million - $4.56 Million
11,035 Added 16976.92%
11,100 $4.49 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $14,788 - $20,324
65 New
65 $19,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.